跳至主要内容
临床试验/NL-OMON26136
NL-OMON26136已完成不适用

Immunogenicity of alternative and reduced immunization schedules using the thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniae.

ational Institute for Public Health and theEnvironment (RIVM), Centre for Infectious Disease Control (CIb).0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Infants in good general health, eligible to be vaccinated according to the Dutch national vaccination program. The same health criteria apply as used in well-baby clinics when a child receives a vaccination, e.g. also children with small increases in temperature or cold are seen as children with normal health;
  • 2. The parents have to be willing and able to allow their child to participate in the trial according to the described procedures;

排除标准

  • 1. Children elegible for the Hepatitis B vaccination;
  • 2. Previous Prevenar and DTaP-IPV-Hib vaccination;

研究者

发起方
ational Institute for Public Health and theEnvironment (RIVM), Centre for Infectious Disease Control (CIb).

相似试验

已完成
4 期
Immunogenicity of alternative and reduced immunization schedules using the thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniaepneumococcal infectionStreptococcus Pneumoniae10004018
NL-OMON35410RIVM400
进行中(未招募)
不适用
Immunogenicity of alternate and reduced immunization schedules using the regular thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniae - Pneumococcal vaccination: reduced and different scheduleImmunogenicity of alternate and reduced immunization schedules using the regular thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniae
EUCTR2009-014315-12-NLCIB/RIVM
进行中(未招募)
不适用
ong Term Follow-up (LTFU) study 16-20 yrs after vaccine dose of hepatitis b with/without Hepatitis B immunoglobulin (HBIG) in newborns to Hepatitis B envelope antigen positive (HBeAg+) mothers.Vaccination of healthy newborns of HBsAg+ and/or HBeAg+ mothers against Hepatitis.
EUCTR2011-004879-36-Outside-EU/EEAGlaxoSmithKline Biologicals69
尚未招募
4 期
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunizatio
CTRI/2017/02/007793Panacea Biotec Ltd800
已完成
不适用
Comparison of immunogenicity and short term reactogencity of MMR vaccineMMR.Need for immunization against measles-mumps-rubella [MMR]
IRCT138806252471N1Deputy of food and drugs, Ministry of health and Medical Education720
Immunogenicity of alternative and reduced... | 临床试验